ASSERT (Acute Sacral inSufficiEncy fractuRe augmenTation): randomised controlled, feasibility trial in older people

Objective To determine the feasibility of designing and conducting a definitive trial to evaluate the effectiveness of sacral fracture fixation compared with non-surgical management among older people admitted with a lateral compression pelvic fragility fracture (PFF).Design Single-site, parallel, t...

Full description

Saved in:
Bibliographic Details
Main Authors: Cassandra Brookes, Matthew Jones, Avril Drummond, Paul Leighton, Paul Hendrick, Terence Ong, Khalid Salem, Nasir Quraishi, Ana Suazo Di Paola, Opinder Sahota
Format: Article
Language:English
Published: BMJ Publishing Group 2022-05-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/5/e050535.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850184685617938432
author Cassandra Brookes
Matthew Jones
Avril Drummond
Paul Leighton
Paul Hendrick
Terence Ong
Khalid Salem
Nasir Quraishi
Ana Suazo Di Paola
Opinder Sahota
author_facet Cassandra Brookes
Matthew Jones
Avril Drummond
Paul Leighton
Paul Hendrick
Terence Ong
Khalid Salem
Nasir Quraishi
Ana Suazo Di Paola
Opinder Sahota
author_sort Cassandra Brookes
collection DOAJ
description Objective To determine the feasibility of designing and conducting a definitive trial to evaluate the effectiveness of sacral fracture fixation compared with non-surgical management among older people admitted with a lateral compression pelvic fragility fracture (PFF).Design Single-site, parallel, two-arm randomised controlled feasibility trial.Setting A UK tertiary centre hospital.Participants Patients aged ≥70 years who were ambulating pre-injury requiring hospital admission (within 28 days of injury) with a type 1 lateral compression PFF.Interventions The intervention group received sacral fracture fixation (cement augmentation±screw fixation) within 7 days of randomisation. Routine preoperative and postoperative care followed each surgical intervention. The control group received usual care consisting of analgesia, and regular input from the medical and therapy team.Primary and secondary outcome measures The feasibility outcomes were the number of eligible patients, willingness to be randomised, adherence to allocated treatment, retention, data on the completeness and variability of the proposed definitive trial outcome measures, and reported adverse events.Results 241 patients were screened. 13 (5.4%) were deemed eligible to participate. Among the eligible participants, nine (69.2%) were willing to participate. Five participants were randomised to the intervention group and four to the control group. The clinicians involved were willing to allow their patients to be randomised and adhere to the allocated treatment. One participant in the intervention group and two participants in the control group received their allocated treatment. All participants were followed up until 12 weeks post-randomisation, and had an additional safety follow-up assessment at 12 months. Overall, the proportion of completeness of outcome measures was at least 75%. No adverse events were directly related to the trial.Conclusions There were significant challenges in recruiting sufficient participants which will need to be addressed prior to a definitive trial.Trial registration number ISRCTN16719542.
format Article
id doaj-art-a0458ec6167742a7b91043d874da8d3c
institution OA Journals
issn 2044-6055
language English
publishDate 2022-05-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-a0458ec6167742a7b91043d874da8d3c2025-08-20T02:16:59ZengBMJ Publishing GroupBMJ Open2044-60552022-05-0112510.1136/bmjopen-2021-050535ASSERT (Acute Sacral inSufficiEncy fractuRe augmenTation): randomised controlled, feasibility trial in older peopleCassandra Brookes0Matthew Jones1Avril Drummond2Paul Leighton3Paul Hendrick4Terence Ong5Khalid Salem6Nasir Quraishi7Ana Suazo Di Paola8Opinder Sahota93 Leicester Clinical Trials Unit, University of Leicester, Leicester, UKNeurology, Manchester Centre for Clinical Neurosciences, Salford Royal Hospital, Salford, UKSchool of Health Sciences, University of Nottingham, Nottingham, UKSchool of Medicine, Queens Medical Centre, University of Nottingham, Nottingham, NG7 2UH, UK5 School of Health Sciences, Faculty of Medicine & Health Sciences, University of Nottingham, Nottingham, UK1 Department of Healthcare for Older People, Nottingham University Hospitals NHS Trust, Nottingham, UK7 Centre for Spinal Studies and Surgery, Nottingham University Hospitals NHS Trust, Nottingham, UK7 Centre for Spinal Studies and Surgery, Nottingham University Hospitals NHS Trust, Nottingham, UK3 Leicester Clinical Trials Unit, University of Leicester, Leicester, UK1 Department of Healthcare for Older People, Nottingham University Hospitals NHS Trust, Nottingham, UKObjective To determine the feasibility of designing and conducting a definitive trial to evaluate the effectiveness of sacral fracture fixation compared with non-surgical management among older people admitted with a lateral compression pelvic fragility fracture (PFF).Design Single-site, parallel, two-arm randomised controlled feasibility trial.Setting A UK tertiary centre hospital.Participants Patients aged ≥70 years who were ambulating pre-injury requiring hospital admission (within 28 days of injury) with a type 1 lateral compression PFF.Interventions The intervention group received sacral fracture fixation (cement augmentation±screw fixation) within 7 days of randomisation. Routine preoperative and postoperative care followed each surgical intervention. The control group received usual care consisting of analgesia, and regular input from the medical and therapy team.Primary and secondary outcome measures The feasibility outcomes were the number of eligible patients, willingness to be randomised, adherence to allocated treatment, retention, data on the completeness and variability of the proposed definitive trial outcome measures, and reported adverse events.Results 241 patients were screened. 13 (5.4%) were deemed eligible to participate. Among the eligible participants, nine (69.2%) were willing to participate. Five participants were randomised to the intervention group and four to the control group. The clinicians involved were willing to allow their patients to be randomised and adhere to the allocated treatment. One participant in the intervention group and two participants in the control group received their allocated treatment. All participants were followed up until 12 weeks post-randomisation, and had an additional safety follow-up assessment at 12 months. Overall, the proportion of completeness of outcome measures was at least 75%. No adverse events were directly related to the trial.Conclusions There were significant challenges in recruiting sufficient participants which will need to be addressed prior to a definitive trial.Trial registration number ISRCTN16719542.https://bmjopen.bmj.com/content/12/5/e050535.full
spellingShingle Cassandra Brookes
Matthew Jones
Avril Drummond
Paul Leighton
Paul Hendrick
Terence Ong
Khalid Salem
Nasir Quraishi
Ana Suazo Di Paola
Opinder Sahota
ASSERT (Acute Sacral inSufficiEncy fractuRe augmenTation): randomised controlled, feasibility trial in older people
BMJ Open
title ASSERT (Acute Sacral inSufficiEncy fractuRe augmenTation): randomised controlled, feasibility trial in older people
title_full ASSERT (Acute Sacral inSufficiEncy fractuRe augmenTation): randomised controlled, feasibility trial in older people
title_fullStr ASSERT (Acute Sacral inSufficiEncy fractuRe augmenTation): randomised controlled, feasibility trial in older people
title_full_unstemmed ASSERT (Acute Sacral inSufficiEncy fractuRe augmenTation): randomised controlled, feasibility trial in older people
title_short ASSERT (Acute Sacral inSufficiEncy fractuRe augmenTation): randomised controlled, feasibility trial in older people
title_sort assert acute sacral insufficiency fracture augmentation randomised controlled feasibility trial in older people
url https://bmjopen.bmj.com/content/12/5/e050535.full
work_keys_str_mv AT cassandrabrookes assertacutesacralinsufficiencyfractureaugmentationrandomisedcontrolledfeasibilitytrialinolderpeople
AT matthewjones assertacutesacralinsufficiencyfractureaugmentationrandomisedcontrolledfeasibilitytrialinolderpeople
AT avrildrummond assertacutesacralinsufficiencyfractureaugmentationrandomisedcontrolledfeasibilitytrialinolderpeople
AT paulleighton assertacutesacralinsufficiencyfractureaugmentationrandomisedcontrolledfeasibilitytrialinolderpeople
AT paulhendrick assertacutesacralinsufficiencyfractureaugmentationrandomisedcontrolledfeasibilitytrialinolderpeople
AT terenceong assertacutesacralinsufficiencyfractureaugmentationrandomisedcontrolledfeasibilitytrialinolderpeople
AT khalidsalem assertacutesacralinsufficiencyfractureaugmentationrandomisedcontrolledfeasibilitytrialinolderpeople
AT nasirquraishi assertacutesacralinsufficiencyfractureaugmentationrandomisedcontrolledfeasibilitytrialinolderpeople
AT anasuazodipaola assertacutesacralinsufficiencyfractureaugmentationrandomisedcontrolledfeasibilitytrialinolderpeople
AT opindersahota assertacutesacralinsufficiencyfractureaugmentationrandomisedcontrolledfeasibilitytrialinolderpeople